LAB EBITDA Margin
Standard Biotools Inc · EBITDA Margin
LAB EBITDA Margin
Latest reported-110.38%period ending
LAB TTM EBITDA Margin (-47.36% → -110.38%)
TTM ebitda margin
High-resolution chart · PNG
LAB ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -110.381% | |
| -94.5847% | |
| -102.768% | |
| -85.8906% | |
| -61.3828% | |
| -64.3366% | |
| -58.1991% | |
| -57.984% | |
| -61.6423% | |
| -51.9198% | |
| -48.7051% | |
| -50.2268% | |
| -61.4412% | |
| -117.5295% | |
| -177.2063% | |
| -149.1794% | |
| -131.9313% | |
| -80.8096% | |
| -33.8993% | |
| -37.3346% | |
| -28.0245% | |
| -25.6278% | |
| -23.7014% | |
| -22.5178% | |
| -33.0208% | |
| -34.5014% | |
| -39.7644% | |
| -38.8899% | |
| -38.8612% | |
| -38.0312% | |
| -29.9547% | |
| -29.222% | |
| -30.4892% | |
| -33.7888% | |
| -38.617% | |
| -48.9595% | |
| -53.7955% | |
| -53.8445% | |
| -54.0203% | |
| -48.0778% | |
| -39.9979% | |
| -36.5138% | |
| -36.5167% | |
| -34.7778% | |
| -38.2867% | |
| -40.0005% | |
| -42.5594% | |
| -42.3662% | |
| -37.8231% | |
| -32.7417% | |
| -18.6983% | |
| -19.3372% | |
| -21.356% | |
| -24.1757% | |
| -31.6295% | |
| -32.8381% | |
| -35.0363% | |
| -42.0721% | |
| -41.773% | |
| -42.9743% | |
| -42.2009% | |
| -38.5555% | |
| -40.2443% | |
| -47.3563% |